Development and optimization of metoprolol succinate gastroretentive drug delivery system

Acta Pharmaceutica

Volumn 60, Issue 4, 2010, Pages 415-425

  Boldhane, Sanjay ^a   Kuchekar, Bhanudas ^b  

^a Piramal Enterprises Limited   (India)

^b MAEER S MAHARASHTRA INSTITUTE OF PHARMACY   (India)

Author keywords

Box Behnken design; Controlled release; Floating tablets; Gastroretention; Metoprolol succinate; Release kinetics

Indexed keywords

ALGINIC ACID; BICARBONATE; CARBOXYMETHYLCELLULOSE; CROSS LINKING REAGENT; GELLING AGENT; MAGNESIUM ALUMINO METASILICATE; METOPROLOL SUCCINATE; UNCLASSIFIED DRUG;

ARTICLE; CONTROLLED DRUG RELEASE; CONTROLLED STUDY; DRUG DELIVERY SYSTEM; DRUG DESIGN; DRUG RELEASE; DRUG SOLUBILITY; GASTRORETENTIVE CONTROLLED DRUG RELEASE; IN VITRO STUDY; TABLET DISINTEGRATION TIME; TABLET FORMULATION; TABLET FRIABILITY; TABLET HARDNESS; TABLET THICKNESS;

EID: 78650576551     PISSN: 13300075     EISSN: 18469558     Source Type: Journal    
DOI: 10.2478/v10007-010-0031-x     Document Type: Article

References (15)

1. B. N. Singh and K. H. Kim, Floating drug delivery systems: An approach to oral controlled drug delivery via gastric retention, J. Control. Rel. 63 (2000) 235-259.
2. S. Arora, J. Ali, A. Ahuja, R. K. Khar and S. Baboota, Floating drug delivery systems: A review, AAPS PharmSciTech 6 (2005) 372-390.
3. R. Bomma, R. A. S. Naidu, M. R. Yamsani and K. Veerabrahma, Development and evaluation of gastroretentive norfloxacin floating tablets, Acta Pharm. 59 (2009) 211-221; DOI: 10.2478/ v10007-009-0019-6.
4. S. T. Prajapati, L. D. Patel and D. M. Patel, Gastric floating matrix tablets: Design and optimization using combination of polymers, Acta Pharm. 58 (2008) 221-229; DOI: 10.2478/v10007-008- -0006-3. (Pubitemid 351777173)
5. S. K. Mishra and K. Pathak, Formulation and evaluation of oil entrapped gastroretentive floating gel beads of loratadine, Acta Pharm. 58 (2008) 187-197; DOI: 10.2478/v10007-008-0001-8. (Pubitemid 351777179)
6. J. G. Hardman, L. E. Limbird, A. G. Gilman (Eds.), Goodman and Gilman's: The Pharmacological Basis of Therapeutics, 10th ed., McGraw-Hill Publishers, New York 2001, pp. 255-256.
7. M. J. Kendall, S. R. Maxwell, A. Sandberg and G. Westergren, Controlled release metoprolol. Clinical pharmacokinetic and therapeutic implications, Clin. Pharmacokin. 21 (1991) 319-330.
8. G. Jobin, A. Cortot, J. Godbillon, M. Duval, J. P. Schoeller, J. Hirtz and J. J. Bernier, Investigation of drug absorption from the gastrointestinal tract of man. I. Metoprolol in stomach, duodenum, and jejunum, Br. J. Clin. Pharmacol. 19 (1985) 97-105.
9. C. Narendra, M. S. Srinath and G. Babu, Optimization of bilayer floating tablet containing metoprolol tartrate as a model drug for gastric retention, AAPS PharmSciTech. 7 (2006) 23-29; DOI: 10.1208/pt070234.
10. H. Ravishankar, P. Patil, A. Samel, H-U. Petereit, R. Lizio and J. Iyer-Chavan, Modulated release metoprolol succinate formulation based on ionic interactions: In-vivo proof of concept, J. Control. Rel. 111 (2006) 65-72.
11. United States Pharmacopoeia 30, National Formulary 25, USP Convention, Rockville 2007, p. 2648.
12. M. Rosa, H. Zia and T. Rhodes, Dosing and testing in-vitro of a bioadhesive and floating drug delivery system for oral application, Int. J. Pharm. 105 (1994) 65-70; DOI: 10.1016/0378-5173 (94) 90236-4.
13. T. Higuchi, Rate of release of medicaments from ointment bases containing drugs in suspensions, J. Pharm. Sci. 50 (1961) 874-875.
14. R. W. Korsmeyer, R. Gurny, E. Doelker, P. Buri and N. A. Peppas, Mechanisms of solute release from porous hydrophilic polymers, Int. J. Pharm. 15 (1983) 25-35; DOI: 10.1016/0378-5173(83) 90064-9.
15. N. A. Peppas, Analysis of Fickian and non-Fickian drug release from polymers, Pharm. Acta Helv. 60 (1985) 110-111.